Navigation Links
Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer
Date:5/31/2009

PALO ALTO, Calif., May 31 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(R) (canfosfamide HCl) in combination with pegylated liposomal doxorubicin (PLD) vs. PLD alone in second-line therapy in platinum refractory or resistant ovarian cancer.

Study Design: Patients with platinum refractory or resistant ovarian cancer (platinum refractory, primary platinum resistant, secondary platinum resistant) by standard GOG criteria, with measurable disease were eligible for enrollment in the trial. A total of 125 patients at sites in the USA (44), Brazil (15), Belgium (8) and UK (6) were randomized with a 1:1 allocation to receive either TELCYTA in combination with PLD (administered IV at doses of 1000 mg/m2 and 50 mg/m2, respectively, every four weeks), or PLD alone (at 50 mg/m2 every four weeks). Patients were treated until tumor progression or unacceptable toxicity. Tumor assessments were conducted every 2 cycles or 8 weeks.

The trial design provided for the enrollment of 244 patients. The trial was interrupted by a clinical hold from June 2007 until October 2007. At the time of the clinical hold, 125 patients had been enrolled in the trial. As a result, 35 patients (21 on the combination treatment and 14 on PLD alone) were discontinued from their study treatment(s) and did not complete their assigned per protocol therapy. Although enrollment was permitted after the release of the clinical hold, Telik decided not to enroll additional patients, which impacted the powering of the study.

Patient Demographics: The treatment arms were well-balanced for patient demographics and
'/>"/>

SOURCE Telik, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Telik Announces Preclinical Presentations at AACR Annual Meeting
2. Telik Announces Fourth Quarter and 2008 Year End Financial Results and 2009 Financial Guidance
3. Telik Announces Year-End Financial Release, Conference Call and Webcast
4. Telik Announces Patents on Compounds Related to TELINTRA
5. Telik Announces Preclinical Presentations at AACR Annual Meeting
6. Telik Reports Positive Results From Phase 1 Dose-Escalation Study of TELINTRA Tablets in Myelodysplastic Syndrome
7. Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology
8. Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
9. AGA Institute presents cutting-edge research during DDW
10. The Pediatric IBD Center at Cedars-Sinai Medical Center Presents Rock-n-Reel 2009 Honoring Alexandra Milchan-Lambert & Scott Lambert
11. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2013)... Cambridge House of O'Fallon , ... Senior Health and Fitness Day with an afternoon of ... on Tuesday, May 29. , The community, which is ... older adults of all incomes, including those on Medicaid, ... A Walgreens representative will be discussing the importance of ...
(Date:5/26/2013)... 26, 2013 Beautologie ( http://www.beautologie.com ), ... in Bakersfield, Malibu and Fresno, has recently been honored ... the annual “Best of Bakersfield” Award, and has also ... , The “Best of Bakersfield” Award is based on ... own favorite businesses in the area. As such, the ...
(Date:5/25/2013)... May 26, 2013 Health food ... of development, China health food industry has formed ... the sales revenue of the health food industry ... 4.8%. , In China, health food falls into ... Health and Herbal/Traditional Products; wherein, Vitamin & Dietary ...
(Date:5/25/2013)... 2013 Imagine running the air conditioner with ... hot air and wasted energy! If the home has a ... or clothes dryer, that may be just what is occurring ... overlooked holes waste energy in the form of higher energy ... loss in the home. , Drafts occur through the small ...
(Date:5/25/2013)... York (PRWEB) May 25, 2013 Life ... which are used to detect and create a new ... test reading and are also known as biotechnology reagents. ... bioscience, diagnosis and education. , This market is driven ... reagents in the field of therapeutics, growth in research ...
Breaking Medicine News(10 mins):Health News:St. Louis Metro East Affordable Assisted Living Community to Host Senior Health and Fitness Day 2Health News:Beautologie Wins Best of Bakersfield Award for 9th Year Running 2Health News:China Health Food Industry Analysis and 2015 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3
... of Medicine researchers have found that climate change may lead ... room (ER) visits in the next decade. The data, ... Preventive Medicine, found that changing levels of ozone could lead ... by children, ages 0-17. The research team, ...
... News) -- The extent of heart muscle damage in heart ... the aorta -- the body,s main artery from the heart ... known as angioplasty, a new study finds. The balloon ... blood supply to the heart in order to reduce its ...
... multicentre open-label study evaluating the efficacy and safety of ... found that 24 months, duration of dual therapy is ... cardiac events. However, the PROlonging Dual antiplatelet ... found a consistently greater risk of haemorrhage in the ...
... today at the ESC Congress 2011, show that TAVI implantation ... in the high Euroscore group (p=0.1). "The most ... month in the low Euroscore group, versus a mortality rate of ... stenosis is the most frequently acquired valve disease in adults. 2% ...
... prior to angioplasty in patients with acute myocardial infarction ... damage, a condition referred to as infarct size, according ... Center researchers. The findings were published online ... Association ( JAMA ), and presented at the ...
... News) -- Although older Americans have many Medicare options ... decisions about their coverage, according to a new study. ... brain function -- can become overwhelmed by the variety ... them from finding the best plan to fit their ...
Cached Medicine News:Health News:Heart Attack Damage Not Reduced by Adding Balloon Pump to Angioplasty 2Health News:Assessing the most appropriate duration of dual antiplatelet therapy after coronary stenting 2Health News:Assessing the most appropriate duration of dual antiplatelet therapy after coronary stenting 3Health News:Transcatheter aortic valve implantation with the Edwards valve prosthesis in patients with low 2Health News:Study shows balloon pump use prior to angioplasty does not reduce heart muscle damage 2Health News:Some Older Americans Overwhelmed by Medicare Options, Study Says 2Health News:Some Older Americans Overwhelmed by Medicare Options, Study Says 3
(Date:5/24/2013)... ANGELES , May 24, 2013  An international ... on Saturday, May 18, in Santa Monica, ... on new lung-sparing therapies for MPM, a rare form ... commonly affects the pleura, the lining of the chest. ... Lung and Blood Institute, the 3rd Annual International Symposium ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. ... management will participate in the Deutsche Bank Health Care ... Boston Waterfront Hotel.  Mr. Adrian Adams ... present an overview of the Company and its product ... 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... , May 24, 2013 The ... for systemic delivery of therapeutic agents has been receiving ... drug delivery showing significant promise. The crucial formulation considerations ... delivery device play a major role in the efficiency ... in the development of new formulation techniques and devices ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... March 15, 2011 Cynosure, Inc. (Nasdaq: ... for minimally invasive and non-invasive aesthetic applications, today announced ... and non-invasive cellulite reduction have received key international regulatory ... Medical Device License authorizing the sale in Canada of ...
... NewCardio, Inc. (OTC Bulletin Board: NWCI ), a cardiovascular ... its Form 10-K for the year ended December 31, 2010 on ... provide a corporate update and discuss progress as follows: ... When : 1:30 p.m. PT/ 4:30 p.m. ET, Tuesday, March 29, ...
Cached Medicine Technology:Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 2Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 3NewCardio to Conduct Corporate Update Conference Call on March 29, 2011 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: